EUCTR2009-017625-20-FIActive, not recruitingNot Applicable
Continuous ropivacaine infusion in treatment of postoperative pain in cardiac surgery.
Pawel Florkiewicz0 sites90 target enrollmentStarted: May 3, 2010Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Continuous peritoneal infusion of ropivacaine following laparoscopy for postoperative analgesia in children: a randomized, double-blind, placebo-controlled study. - Peritoneal infusion of ropivacaine following laparoscopy in children.EUCTR2008-002724-29-ITISTITUTO PER L'INFANZIA BURLO GAROFOLO
Completed
Phase 4
Comparison of ropivacaine (a local anaesthetic) and ropivacaine with fentanyl (an analgesic) injected adjacent to thoracic vertebra to provide pain relief in patients with multiple rib fracturesCTRI/2012/12/003187niversity College of Medical Sciences and Guru Teg Bahadur Hospital30
Completed
Not Applicable
Ropivacaine for pain management in patients who undergo Caesarean sectioISRCTN15849443Mexican Social Security Institute81
Completed
Phase 2
Intraperitoneal Instillation of Ropivacaine for Postoperative Pain Relief in Laparoscopic Sleeve GastrectomyTCTR20220717002one110
Active, not recruiting
Not Applicable
Peritoneal nebulization of Ropivacaine for postoperative pain control after laparoscopic cholecystectomy A multicentre, randomized, controlled, double blinded, phase III clinical trial; comparing preoperative peritoneal nebulization of Ropivacaine 100 mg or 150 mg with preoperative peritoneal nebulization of Ropivacaine 50 mg in the peritoneal cavity - AR HSG 01 2010EUCTR2009-018247-24-ITAZIENDA OSPEDALIERA SAN GERARDO DI MONZA
